Alignment Healthcare Reports Strong Q3 2025 Results, Raises Full-Year Guidance to Surpass High-End Expectations

ALHC
November 02, 2025

Alignment Healthcare, Inc. reported robust financial results for its third quarter ended September 30, 2025, surpassing the high-end of guidance across all key metrics. Total revenue for Q3 2025 reached $993.7 million, a 43.5% increase year-over-year from Q3 2024, with health plan membership growing nearly 26% to 228,600.

The company achieved an adjusted gross profit of $128.5 million, up 45.5% year-over-year, and reported positive adjusted EBITDA of $25.5 million, compared to a loss of $2.5 million in Q3 2024. The Medical Benefits Ratio improved to 87.2% from 88.4% in the prior year period, demonstrating effective cost management.

Notably, Alignment Healthcare reported GAAP net income of $3.7 million, or $0.02 per share, marking its second consecutive profitable quarter as a publicly traded company. This sustained profitability underscores the efficacy of its care management model.

Building on this performance, the company significantly raised its full-year 2025 financial guidance, now expecting revenue between $3.93 billion and $3.95 billion, adjusted gross profit between $474 million and $483 million, and adjusted EBITDA between $90 million and $98 million. This updated outlook reflects strong confidence in continued growth and margin expansion.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.